PubMed

Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.

Prandoni P, Prins MH, Lensing AW, Ghirarduzzi A, Ageno W, Imberti D, Scannapieco G, Ambrosio GB, Pesavento R, Cuppini S, Quintavalla R, Agnelli G; AESOPUS Investigators.

Ann Intern Med. 2009 May 5;150(9):577-85.PMID: 19414836 [PubMed - indexed for MEDLINE]Related articlesFree article

The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A.

Haematologica. 2007 Feb;92(2):199-205.PMID: 17296569 [PubMed - indexed for MEDLINE]Related articlesFree article

Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism.

Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P, Frulla M, Mosena L, Tormene D, Piccioli A, Simioni P, Girolami A.

Ann Intern Med. 2002 Dec 17;137(12):955-60.PMID: 12484710 [PubMed - indexed for MEDLINE]Related articlesFree article

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study.

Siragusa S, Malato A, Anastasio R, Cigna V, Milio G, Amato C, Bellisi M, Attanzio MT, Cormaci O, Pellegrino M, Dolce A, Casuccio A, Bajardi G, Mariani G.

Blood. 2008 Aug 1;112(3):511-5. Epub 2008 May 22.PMID: 18497320 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Epub 2007 Oct 1. Review.PMID: 17906973 [PubMed - indexed for MEDLINE]Related articles

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.

Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I, Nony P, Sanson C, Boissel JP; Investigators of the "Durée Optimale du Traitement AntiVitamines K" (DOTAVK) Study.

Circulation. 2001 May 22;103(20):2453-60.PMID: 11369685 [PubMed - indexed for MEDLINE]Related articlesFree article

Withholding anticoagulation after a negative result on duplex ultrasonography for suspected symptomatic deep venous thrombosis.

Stevens SM, Elliott CG, Chan KJ, Egger MJ, Ahmed KM.

Ann Intern Med. 2004 Jun 15;140(12):985-91.PMID: 15197015 [PubMed - indexed for MEDLINE]Related articlesFree article

D-dimer testing to determine the duration of anticoagulation therapy.

Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A, Pattacini C, Testa S, Lensing AW, Tripodi A; PROLONG Investigators.

N Engl J Med. 2006 Oct 26;355(17):1780-9. Erratum in: N Engl J Med. 2006 Dec 28;355(26):2797. PMID: 17065639 [PubMed - indexed for MEDLINE]Related articlesFree article

Oral anticoagulant therapy in venous thromboembolism.

Cosmi B, Palareti G.

Semin Vasc Med. 2003 Aug;3(3):303-14. Review.PMID: 15199464 [PubMed - indexed for MEDLINE]Related articles

The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.

Jiménez D, Díaz G, Marín E, Vidal R, Sueiro A, Yusen RD.

Thromb Haemost. 2006 Mar;95(3):562-6.PMID: 16525588 [PubMed - indexed for MEDLINE]Related articles

The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.

Douketis JD, Gu CS, Schulman S, Ghirarduzzi A, Pengo V, Prandoni P.

Ann Intern Med. 2007 Dec 4;147(11):766-74.PMID: 18056660 [PubMed - indexed for MEDLINE]Related articlesFree article

Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.

Andreozzi GM.

Minerva Cardioangiol. 2007 Dec;55(6):741-53.PMID: 18091643 [PubMed - indexed for MEDLINE]Related articles

Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial.

Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE.

Ann Intern Med. 2007 Oct 16;147(8):525-33.PMID: 17938390 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Pinede L, Ninet J, Duhaut P et al for the Investigators of the 'Durée Optimale du Traitement Antivitamines K' (DOTAVK) study. Circulation 2001; 103: 2453-60.

Anand SS.

Vasc Med. 2001 Nov;6(4):269-70.PMID: 11958396 [PubMed - indexed for MEDLINE]Related articles

Extended oral anticoagulant therapy after a first episode of pulmonary embolism.

Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M, Imberti D, Poggio R, Ageno W, Pogliani E, Porro F, Zonzin P; Warfarin Optimal Duration Italian Trial Investigators.

Ann Intern Med. 2003 Jul 1;139(1):19-25.PMID: 12834314 [PubMed - indexed for MEDLINE]Related articlesFree article

Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.

Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W; Warfarin Optimal Duration Italian Trial Investigators.

N Engl J Med. 2001 Jul 19;345(3):165-9.PMID: 11463010 [PubMed - indexed for MEDLINE]Related articlesFree article

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

Schulman S, Granqvist S, Holmström M, Carlsson A, Lindmarker P, Nicol P, Eklund SG, Nordlander S, Lärfars G, Leijd B, Linder O, Loogna E.

N Engl J Med. 1997 Feb 6;336(6):393-8.PMID: 9010144 [PubMed - indexed for MEDLINE]Related articlesFree article

6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII.

Eischer L, Gartner V, Schulman S, Kyrle PA, Eichinger S; AUREC-FVIII investigators.

Ann Hematol. 2009 May;88(5):485-90. Epub 2008 Oct 18.PMID: 18931845 [PubMed - indexed for MEDLINE]Related articles

Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.

Gonzalez-Fajardo JA, Arreba E, Castrodeza J, Perez JL, Fernandez L, Agundez I, Mateo AM, Carrera S, Gutiérrez V, Vaquero C.

J Vasc Surg. 1999 Aug;30(2):283-92.PMID: 10436448 [PubMed - indexed for MEDLINE]Related articles

Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors.

Hansson PO, Sörbo J, Eriksson H.

Arch Intern Med. 2000 Mar 27;160(6):769-74.PMID: 10737276 [PubMed - indexed for MEDLINE]Related articlesFree article